Year : 2009 | Volume
: 2 | Issue : 3 | Page : 143--144
VMD2 mutational analysis in a Japanese family with Best macular dystrophy
Satomi Shiose, Shigeo Yoshida, Keijiro Ishikawa, Tatsuro Ishibashi
Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
Department of Ophthalmology, Kyushu University Graduate School of Medical Sciences, Fukuoka, 812-8582
|How to cite this article:|
Shiose S, Yoshida S, Ishikawa K, Ishibashi T. VMD2 mutational analysis in a Japanese family with Best macular dystrophy.Oman J Ophthalmol 2009;2:143-144
|How to cite this URL:|
Shiose S, Yoshida S, Ishikawa K, Ishibashi T. VMD2 mutational analysis in a Japanese family with Best macular dystrophy. Oman J Ophthalmol [serial online] 2009 [cited 2021 Apr 11 ];2:143-144
Available from: https://www.ojoonline.org/text.asp?2009/2/3/143/57317
Best macular dystrophy (BMD) is an early-onset, autosomal dominantly inherited disorder characterized by an egg yolk like yellowish macular lesion.  The appearance of the fundus of patients with BMD varies depending on the stage of disease and may be almost normal in the early stages.  Abnormal electro-oculography (EOG) is considered a useful indicator of the disease and is used in its diagnosis. It was recently reported that mutations of the VMD2 gene is responsible for BMD.  VMD2 is an RPE-specific gene encoding bestrophin, a protein of unknown function. The onset and penetrance of the VMD2 gene is varied, and several cases of BMD with different degrees of severity have been reported mainly in the Western world.
A 37-year-old Japanese woman was seen at Kyushu University complaining of blurred vision in her left eye. No member of her family had previously presented with or had symptoms of BMD. Her best-corrected visual acuity was 20/20 OD and 20/25 OS, and the intraocular pressures and anterior segments were normal. Fundus examination revealed typical scrambled egg-like lesions in the macula of both eyes [Figure 1]A. Optical coherence tomography (OCT; Carl Zeiss, Germany) of the yellowish lesion revealed a highly reflective, spindle-shape zone [Figure 1]B. Fluorescein angiography demonstrated hyper-fluorescence due to a window defect from the RPE atrophy, and hypo-fluorescence corresponding to the egg-like deposit from the early stage. Visual field, color vision tests, cone and rod ERGs were normal, but the multifocal ERGs were reduced in the macular area compared with those in a normal control [Figure 1]C. The light rise in the EOG was reduced (Arden ratio was 1.5 in the right eye and 1.3 in the left eye). Based on the clinical findings a diagnosis of BMD was made.
These clinical findings led us to recommend that other family members undergo ocular examinations. Fundus examination of the patient's 12-year-old asymptomatic son, whose visual acuity was 20/20 OU, was almost normal showing only bilateral irregular reflex in the macula [Figure 1]D. Although we tentatively diagnosed the son as not having BMD, we could not completely exclude the possibility that he was an asymptomatic or preclinical carrier because of the variable expressivity of BMD. Because of her son's lack of symptoms and because of the time-consuming nature of the examinations, the mother declined to let her son undergo any further ocular examinations including the EOG. However, she did agree to blood being taken both from herself and her son for molecular genetic analysis.
After obtaining informed consent, blood was drawn, and direct sequencing  of all coding regions of the VMD2 gene revealed a mutation causing a C to T change at nucleotide 584 (Ala195Val) in the mother but not in her son [Figure 2]. This mutation has been reported in a Caucasian  in the VMD2 mutation database (http://www.uni-wuerzburg.de/humangenetics/vmd2.html). None of the other sequence alterations was detected in any of the 64 healthy, unrelated individuals without eye disease used as control subjects. Based on the molecular diagnosis, we were able to inform the mother that the possibility of her son inheriting the disease-causing mutation was very low.
Our case demonstrates the usefulness of the web-based database of mutations in VMD2 for obtaining disease-causing sequence alterations. Increasing numbers of VMD2 mutations are being posted on the web-based database, and it has become easier to identify mutations responsible for BMD. The fact that the same mutation found in the mother had been reported in a Caucasian suggests that the mutation is present in different ethnic groups.
Our study also demonstrated the value of molecular analysis of the VMD2 gene, which can lead to a rapid and accurate diagnosis and the exclusion of BMD. It is a viable alternative to EOG for the diagnosis of BMD, which is currently accepted as the test for an early diagnosis of BMD. However, EOG is difficult to perform in young children, and in clinics where EOG is not available, blood samples or buccal swabs can be sent to a clinic where genetic analyses can be performed.
|1||Best F. Ueber eine hereditaere Maculaaffektion. Z Augenhwilk 1905;13:199-212. |
|2||Schatz P, Klar J, Andrιasson S, Ponjavic V, Dahl N. Variant phenotype of Best vitelliform macular dystrophy associated with compound heterozygous mutations in VMD2. Ophthalmic Genet 2006;27:51-6.|
|3||Petrukhin K, Koisti MJ, Bakall B, Li W, Xie G, Marknell T, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet 1998;19:241-7.|
|4||Yoshida S, Yamaji Y, Yoshida A, Kuwahara R, Yamamoto K, Kubata T, et al. Novel triple missense mutations of GUCY2D gene in Japanese family with Cone-rod dystrophy: Possible use of genotyping microarray. Mol Vis 2006;12:1558-64.|
|5||Lotery AJ, Munier FL, Fishman GA, Weleber RG, Jacobson SG, Affatigato LM, et al. Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci 2000;41:1291-6.|